The Fourth International Workshop on Clinical Transplant Tolerance
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons..
The International Workshop on Clinical Transplant Tolerance is a biennial meeting that aims to provide an update on the progress of studies of immunosuppression minimization or withdrawal in solid organ transplantation. The Fourth International Workshop on Clinical Tolerance was held in Pittsburgh, Pennsylvania, September 5-6, 2019. This report is a summary of presentations on the status of clinical trials designed to minimize or withdraw immunosuppressive drugs in kidney, liver, and lung transplantation without subsequent evidence of rejection. All protocols had in common the use of donor or recipient cell therapy combined with organ transplantation. The workshop also included presentations of mechanistic studies designed to improve understanding of the cellular and molecular basis of tolerance and to identify potential predictors/biomarkers of tolerance. Strategies to enhance the safety of hematopoietic cell transplantation and to improve patient selection/risk stratification for clinical trials were also discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 21(2021), 1 vom: 14. Jan., Seite 21-31 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Issa, Fadi [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 18.06.2021 Date Revised 15.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ajt.16139 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31108897X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31108897X | ||
| 003 | DE-627 | ||
| 005 | 20231225141513.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ajt.16139 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM31108897X | ||
| 035 | |a (NLM)32529725 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Issa, Fadi |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Fourth International Workshop on Clinical Transplant Tolerance |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.06.2021 | ||
| 500 | |a Date Revised 15.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 The American Society of Transplantation and the American Society of Transplant Surgeons. | ||
| 520 | |a The International Workshop on Clinical Transplant Tolerance is a biennial meeting that aims to provide an update on the progress of studies of immunosuppression minimization or withdrawal in solid organ transplantation. The Fourth International Workshop on Clinical Tolerance was held in Pittsburgh, Pennsylvania, September 5-6, 2019. This report is a summary of presentations on the status of clinical trials designed to minimize or withdraw immunosuppressive drugs in kidney, liver, and lung transplantation without subsequent evidence of rejection. All protocols had in common the use of donor or recipient cell therapy combined with organ transplantation. The workshop also included presentations of mechanistic studies designed to improve understanding of the cellular and molecular basis of tolerance and to identify potential predictors/biomarkers of tolerance. Strategies to enhance the safety of hematopoietic cell transplantation and to improve patient selection/risk stratification for clinical trials were also discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a clinical research/practice | |
| 650 | 4 | |a clinical trial | |
| 650 | 4 | |a immune regulation | |
| 650 | 4 | |a immunosuppression/immune modulation | |
| 650 | 4 | |a kidney transplantation/nephrology | |
| 650 | 4 | |a liver transplantation/hepatology | |
| 650 | 4 | |a tolerance: chimerism | |
| 650 | 4 | |a tolerance: clinical | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 700 | 1 | |a Strober, Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Leventhal, Joseph R |e verfasserin |4 aut | |
| 700 | 1 | |a Kawai, Tatsuo |e verfasserin |4 aut | |
| 700 | 1 | |a Kaufman, Dixon B |e verfasserin |4 aut | |
| 700 | 1 | |a Levitsky, Josh |e verfasserin |4 aut | |
| 700 | 1 | |a Sykes, Megan |e verfasserin |4 aut | |
| 700 | 1 | |a Mas, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Wood, Kathryn J |e verfasserin |4 aut | |
| 700 | 1 | |a Bridges, Nancy |e verfasserin |4 aut | |
| 700 | 1 | |a Welniak, Lisbeth A |e verfasserin |4 aut | |
| 700 | 1 | |a Chandran, Sindhu |e verfasserin |4 aut | |
| 700 | 1 | |a Madsen, Joren C |e verfasserin |4 aut | |
| 700 | 1 | |a Nickerson, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Demetris, Anthony J |e verfasserin |4 aut | |
| 700 | 1 | |a Lakkis, Fadi G |e verfasserin |4 aut | |
| 700 | 1 | |a Thomson, Angus W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 21(2021), 1 vom: 14. Jan., Seite 21-31 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:1 |g day:14 |g month:01 |g pages:21-31 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ajt.16139 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2021 |e 1 |b 14 |c 01 |h 21-31 | ||